Semaglutide CAS 910463-68-2 Loss Weight Peptide Tirzepatide Retatrutide
- Արարատ
- 27/12/2024 06:46
Գործակալություն
-
Ընկերության անվանումը
Semaglutide CAS 910463-68-2 Loss Weight Peptide Tirzepatide Retatrutide
-
Աշխատանքային ոլորտ
Առողջապահություն, Դեղագործություն
-
Գրաֆիկ
Լրիվ աշխատանքային օր
-
Կրթություն
Միջնակարգ
-
Փորձ
CAS No. 910463-68-2
Chemical Name: Semaglutide
Synonyms：
semaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;Sermaglutide CAS 910463 68 2;OG217SC;Ozempic;Somaroutin;semgalutide;Somaglutide;Somarlutide
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.57754
Description
Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
Uses
Semaglutide is used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. There have been no published reports of hepatotoxicity attributed to semaglutide therapy. -
Նախընտրելի սեռ
-
Նախընտրելի տարիք
-
Նկարագիր
-
CAS No. 910463-68-2
Chemical Name: Semaglutide
Synonyms：
semaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;Sermaglutide CAS 910463 68 2;OG217SC;Ozempic;Somaroutin;semgalutide;Somaglutide;Somarlutide
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.57754
Description
Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.
Uses
Semaglutide is used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. There have been no published reports of hepatotoxicity attributed to semaglutide therapy.
